Tousi promoted to chief commercial officer at Illumina; plus Kintor, Esperion, AffaMed, Escient and more

Susan Tousi was promoted to chief commercial officer at  Illumina Inc. (NASDAQ:ILMN). Tousi joined the genome sequencing company in 2012 as VP of engineering, and was most recently SVP and chief product officer. Illumina also named Alex Aravanis CTO and head of research and product development. Aravanis, who co-founded Grail Inc. and served as its CSO and head of R&D, rejoined Illumina last year as CTO and SVP. 

Kintor Pharmaceuticals Ltd. (HKEX:9939) hired Qun Lu as CTO and Jiawen Han as VP of business development. Lu was executive director of product development at Bristol Myers Squibb Co. (NYSE:BMY) and Han was VP and head of business development at Qilu Pharmaceutical Co. Ltd...